US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Royalty Pharma plc

46.21

+0.85001.87%

Post-market: 46.210.00000.00%19:01 EST

Volume:4.18M

Turnover:192.65M

Market Cap:26.95B

PE:25.94

High:46.37

Open:45.44

Low:45.26

Close:45.36

52wk High:46.37

52wk Low:29.66

Shares:583.17M

Float Shares:379.85M

Volume Ratio:1.34

T/O Rate:1.10%

Dividend:0.88

Dividend Rate:1.90%

EPS(TTM):1.78

EPS(LYR):1.78

ROE:13.20%

ROA:5.15%

PB:4.16

PE(LYR):25.94

Loading ...

Overview Company News Filings

UBS Upgrades Royalty Pharma to Buy From Neutral, Adjusts Price Target to $49 From $38

MT Newswires Live

Assessing Royalty Pharma (RPRX) Valuation After Teva Autoimmune Funding Partnership Attracts Fresh Attention

Simply Wall St.

Royalty Pharma Is Maintained at Buy by Citigroup

Royalty Pharma EVP Marshall Urist Reports Disposal of Common Shares

EVP Marshall Urist Reports Disposal of Royalty Pharma plc Common Shares

Royalty Pharma plc to Announce Fourth Quarter and Full Year 2025 Financial Results

Royalty Pharma EVP Marshall Urist Reports Sale of Common Shares

Royalty Pharma provides update on business performance

Royalty Pharma Targets 14%-16% Top-Line Growth for 2025

Royalty Pharma to Highlight Accomplishments and Provide Business Update at 44TH Annual J.p. Morgan Healthcare Conference

THOMSON REUTERS

Royalty Pharma, Teva enter agreement to accelerate development of TEV-‘408

BRIEF-Teva And Royalty Pharma Enter Agreement To Accelerate Development Of Potential Treatment For Vitiligo

Teva and Royalty Pharma Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo

THOMSON REUTERS

Teva - Teva to Share Tev-'408 Trial Results in 2026

THOMSON REUTERS

Royalty Pharma - to Provide up to $500 Mln for Teva's Tev-'408

THOMSON REUTERS

Royalty Pharma : Tev-'408 Is Currently in Phase 1B for Treatment of Vitiligo and in Phase 2a for Celiac Disease

THOMSON REUTERS

Teva and Royalty Pharma Partner in $500 Million Deal to Advance TEV-'408 for Vitiligo

Assessing Royalty Pharma (RPRX) Valuation After Dividend Increase And Raised Full Year Guidance

Simply Wall St.

Royalty Pharma Increases Quarterly Dividend to $0.235 a Share From $0.22, Payable March 10 to Holders of Record on Feb. 20.

MT Newswires Live

Royalty Pharma announces $0.235 quarterly dividend

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/RPRX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RPRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RPRX\",,,,,undefined,":{"symbol":"RPRX","market":"US","secType":"STK","nameCN":"Royalty Pharma plc","latestPrice":46.21,"timestamp":1772226000000,"preClose":45.36,"halted":0,"volume":4176944,"hourTrading":{"tag":"盘后","latestPrice":46.21,"preClose":46.21,"latestTime":"19:01 EST","volume":655043,"amount":30269588.051068,"timestamp":1772236883973,"change":0,"changeRate":0,"amplitude":0.000433},"delay":0,"changeRate":0.018738977072310436,"floatShares":379849980,"shares":583174298,"eps":1.781403,"marketStatus":"Market Closed","change":0.85,"latestTime":"02-27 16:00:00 EST","open":45.44,"high":46.37,"low":45.26,"amount":192649971.86512,"amplitude":0.024471,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":1.781403,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1772442000000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1592280000000,"exchange":"NASDAQ","adjPreClose":45.36,"dividendRate":0.019043,"preHourTrading":{"tag":"盘前","latestPrice":45.36,"preClose":45.36,"latestTime":"09:16 EST","volume":87,"amount":3920.7600960000004,"timestamp":1772201760242,"change":0,"changeRate":0,"amplitude":0.007937},"postHourTrading":{"tag":"盘后","latestPrice":46.21,"preClose":46.21,"latestTime":"19:01 EST","volume":655043,"amount":30269588.051068,"timestamp":1772236883973,"change":0,"changeRate":0,"amplitude":0.000433},"volumeRatio":1.340712,"impliedVol":0.2605,"impliedVolPercentile":0.5458},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RPRX\",,,,,undefined,":{"symbol":"RPRX","floatShares":379849980,"roa":"5.15%","roe":"13.20%","lyrEps":1.781403,"volumeRatio":1.340712,"shares":583174298,"dividePrice":0.88,"high":46.37,"amplitude":0.024471,"preClose":45.36,"low":45.26,"week52Low":29.66,"pbRate":"4.16","psRate":"11.33","week52High":46.37,"institutionHeld":0.9297,"latestPrice":46.21,"eps":1.781403,"divideRate":0.019043,"volume":4176944,"delay":0,"ttmEps":1.781403,"open":45.44,"prevYearClose":38.64,"prevWeekClose":45.12,"prevMonthClose":41.68,"prevQuarterClose":38.64,"fiveDayClose":45.12,"twentyDayClose":40.86,"sixtyDayClose":39.9,"dividendPayoutRate":0.4905978045748245,"dividendFrequency":"Q","dividendGrowthYears":5,"dividendGrowthRate":0.047619047619047665,"fiveYearAvgDividendRate":0.02408439366820899},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RPRX\",params:#limit:5,,,undefined,":[{"date":"2026-02-20","symbol":"RPRX","amount":0.235,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-02-20","defaultRemindTime":1771597800000,"name":"Royalty Pharma plc","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-10","payableDate":"2026-02-20","currency":"USD","dateTimestamp":1771563600000,"payDate":"2026-03-10"},{"market":"US","date":"2026-02-11","symbol":"RPRX","fiscalQuarterEnding":"2025/12","expectedEps":1.33,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1770786000000,"reportTimeType":"pre","actualEps":1.46},{"date":"2025-11-14","symbol":"RPRX","amount":0.22,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-11-14","defaultRemindTime":1763130600000,"name":"Royalty Pharma plc","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-10","payableDate":"2025-11-14","currency":"USD","dateTimestamp":1763096400000,"payDate":"2025-12-10"},{"market":"US","date":"2025-11-05","symbol":"RPRX","fiscalQuarterEnding":"2025/09","expectedEps":1.11,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762318800000,"reportTimeType":"pre","actualEps":1.17},{"date":"2025-08-15","symbol":"RPRX","amount":0.22,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-08-15","defaultRemindTime":1755264600000,"name":"Royalty Pharma plc","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-10","payableDate":"2025-08-15","currency":"USD","dateTimestamp":1755230400000,"payDate":"2025-09-10"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RPRX\",market:\"US\",,,undefined,":[{"executeDate":"2020-09-14","recordDate":"2020-09-15","paymentDate":"2020-09-30","value":0.15,"currency":"USD"},{"executeDate":"2020-11-19","recordDate":"2020-11-20","paymentDate":"2020-12-15","value":0.15,"currency":"USD"},{"executeDate":"2021-02-18","recordDate":"2021-02-19","paymentDate":"2021-03-15","value":0.17,"currency":"USD"},{"executeDate":"2021-05-19","recordDate":"2021-05-20","paymentDate":"2021-06-15","value":0.17,"currency":"USD"},{"executeDate":"2021-08-19","recordDate":"2021-08-20","paymentDate":"2021-09-15","value":0.17,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RPRX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3,"buy":0.6,"hold":0.1,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":10,"updateTime":1771390800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RPRX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RPRX","date":"2026-02-26","current":25.940228,"percent":0.457213,"low":9.420627,"twenty":15.379534,"median":26.576164,"eighty":56.189678,"high":536.452748,"avg":54.574818,"sd":101.394966,"marketCap":19343100331},"quantilePoints":[{"date":"2021-03-05","current":26.487628,"twenty":10.814813,"median":12.418558,"eighty":14.081953,"marketCap":25826496409},{"date":"2021-03-12","current":29.214845,"twenty":10.822587,"median":12.523287,"eighty":14.16469,"marketCap":28485642020},{"date":"2021-03-19","current":29.1339,"twenty":10.827252,"median":12.685937,"eighty":14.372357,"marketCap":28406717607},{"date":"2021-03-26","current":26.624611,"twenty":10.830362,"median":12.725867,"eighty":14.420638,"marketCap":25960060801},{"date":"2021-04-01","current":26.780274,"twenty":10.841764,"median":12.736219,"eighty":14.558244,"marketCap":26111838518},{"date":"2021-04-09","current":26.344418,"twenty":10.870271,"median":12.777628,"eighty":14.859728,"marketCap":25686860909},{"date":"2021-04-16","current":26.070451,"twenty":10.877008,"median":12.890883,"eighty":15.364506,"marketCap":25419732126},{"date":"2021-04-23","current":27.153866,"twenty":10.880637,"median":12.943264,"eighty":25.867466,"marketCap":26476105040},{"date":"2021-04-30","current":27.609843,"twenty":10.889966,"median":13.040871,"eighty":26.105319,"marketCap":26920701720},{"date":"2021-05-07","current":25.708529,"twenty":10.902405,"median":13.112851,"eighty":26.233724,"marketCap":25066844306},{"date":"2021-05-14","current":25.415982,"twenty":10.923137,"median":13.188745,"eighty":26.203698,"marketCap":24727692206},{"date":"2021-05-21","current":25.397262,"twenty":11.006583,"median":13.242152,"eighty":26.105319,"marketCap":24709478831},{"date":"2021-05-28","current":25.035336,"twenty":11.014357,"median":13.396752,"eighty":26.063326,"marketCap":24357353580},{"date":"2021-06-04","current":28.211553,"twenty":11.037163,"median":13.462808,"eighty":26.226114,"marketCap":27447556215},{"date":"2021-06-11","current":28.01811,"twenty":11.073444,"median":13.525947,"eighty":26.468948,"marketCap":27259351339},{"date":"2021-06-18","current":27.46898,"twenty":11.088992,"median":13.552567,"eighty":26.637064,"marketCap":26725092338},{"date":"2021-06-25","current":26.570403,"twenty":11.125544,"median":13.593515,"eighty":26.668197,"marketCap":25850850335},{"date":"2021-07-02","current":26.35824,"twenty":11.210793,"median":13.670814,"eighty":26.643499,"marketCap":25644432084},{"date":"2021-07-09","current":26.064954,"twenty":11.239817,"median":13.722576,"eighty":26.638351,"marketCap":25359089208},{"date":"2021-07-16","current":26.726929,"twenty":11.289271,"median":13.759358,"eighty":26.648439,"marketCap":26003137199},{"date":"2021-07-23","current":26.581925,"twenty":11.338048,"median":13.881632,"eighty":26.679943,"marketCap":25862059759},{"date":"2021-07-30","current":25.17802,"twenty":11.350107,"median":13.916375,"eighty":26.648439,"marketCap":24496173638},{"date":"2021-08-06","current":24.380496,"twenty":11.371465,"median":14.057313,"eighty":26.638351,"marketCap":23720247719},{"date":"2021-08-13","current":24.202628,"twenty":11.413966,"median":14.101803,"eighty":26.627102,"marketCap":23515781358},{"date":"2021-08-20","current":24.371352,"twenty":11.425707,"median":14.162722,"eighty":26.606281,"marketCap":23679717867},{"date":"2021-08-27","current":24.490085,"twenty":11.428044,"median":14.303845,"eighty":26.590141,"marketCap":23795080595},{"date":"2021-09-03","current":24.565073,"twenty":11.442485,"median":14.393216,"eighty":26.58299,"marketCap":23867941265},{"date":"2021-09-10","current":24.046401,"twenty":11.483683,"median":14.412385,"eighty":26.575012,"marketCap":23363988295},{"date":"2021-09-17","current":24.058899,"twenty":11.513281,"median":14.476137,"eighty":26.520738,"marketCap":23376131740},{"date":"2021-09-24","current":23.18403,"twenty":11.53978,"median":14.588573,"eighty":26.47642,"marketCap":22526090586},{"date":"2021-10-01","current":22.640362,"twenty":11.560125,"median":14.847176,"eighty":26.437867,"marketCap":21997850726},{"date":"2021-10-08","current":22.177931,"twenty":11.592778,"median":15.062517,"eighty":26.384717,"marketCap":21548543258},{"date":"2021-10-15","current":23.99016,"twenty":11.640462,"median":15.413014,"eighty":26.360183,"marketCap":23309342792},{"date":"2021-10-22","current":23.433993,"twenty":11.659417,"median":22.124814,"eighty":26.350751,"marketCap":22768959487},{"date":"2021-10-29","current":24.702553,"twenty":11.679854,"median":22.271667,"eighty":26.344954,"marketCap":24001519161},{"date":"2021-11-05","current":24.696304,"twenty":11.723704,"median":22.559124,"eighty":26.333991,"marketCap":23995447438},{"date":"2021-11-12","current":32.51009,"twenty":11.752375,"median":22.640362,"eighty":26.350751,"marketCap":25452734666},{"date":"2021-11-19","current":32.2309,"twenty":11.763977,"median":22.8872,"eighty":26.47642,"marketCap":25234152021},{"date":"2021-11-26","current":32.486824,"twenty":11.775219,"median":22.924694,"eighty":26.585121,"marketCap":25434519446},{"date":"2021-12-03","current":29.19859,"twenty":11.807468,"median":23.015305,"eighty":26.640925,"marketCap":22860101627},{"date":"2021-12-10","current":29.291653,"twenty":11.847383,"median":23.171532,"eighty":26.80037,"marketCap":22932962508},{"date":"2021-12-17","current":29.888809,"twenty":11.870433,"median":23.215276,"eighty":26.895847,"marketCap":23400486499},{"date":"2021-12-23","current":31.21496,"twenty":11.891419,"median":23.371502,"eighty":27.107873,"marketCap":24438754063},{"date":"2021-12-31","current":30.904749,"twenty":11.910529,"median":23.48711,"eighty":27.173363,"marketCap":24195884457},{"date":"2022-01-07","current":31.222715,"twenty":11.93171,"median":23.58397,"eighty":27.251023,"marketCap":24444825803},{"date":"2022-01-14","current":30.757399,"twenty":11.982869,"median":23.843307,"eighty":27.501351,"marketCap":24080521395},{"date":"2022-01-21","current":30.354125,"twenty":12.0166,"median":23.915171,"eighty":27.798092,"marketCap":23764790907},{"date":"2022-01-28","current":30.602294,"twenty":12.025032,"median":23.99016,"eighty":27.981993,"marketCap":23959086592},{"date":"2022-02-04","current":30.997812,"twenty":12.078439,"median":24.05265,"eighty":28.604645,"marketCap":24268745339},{"date":"2022-02-11","current":30.912504,"twenty":12.120603,"median":24.152635,"eighty":28.953331,"marketCap":24201956198},{"date":"2022-02-18","current":38.611798,"twenty":12.199308,"median":24.193255,"eighty":29.097649,"marketCap":23928812189},{"date":"2022-02-25","current":37.690836,"twenty":12.300501,"median":24.209173,"eighty":29.140126,"marketCap":23358066605},{"date":"2022-03-04","current":37.641849,"twenty":12.370773,"median":24.296364,"eighty":29.218581,"marketCap":23327707798},{"date":"2022-03-11","current":37.494887,"twenty":12.393263,"median":24.333858,"eighty":29.372308,"marketCap":23236631375},{"date":"2022-03-18","current":38.523621,"twenty":12.400806,"median":24.371352,"eighty":29.55223,"marketCap":23874166335},{"date":"2022-03-25","current":37.592862,"twenty":12.401989,"median":24.41822,"eighty":29.826979,"marketCap":23297348990},{"date":"2022-04-01","current":38.56281,"twenty":12.415244,"median":24.490085,"eighty":30.011342,"marketCap":23898453382},{"date":"2022-04-08","current":40.581088,"twenty":12.46803,"median":24.558469,"eighty":30.160243,"marketCap":25149236257},{"date":"2022-04-14","current":43.206807,"twenty":12.481269,"median":24.62444,"eighty":30.337063,"marketCap":26776468347},{"date":"2022-04-22","current":41.977613,"twenty":12.531575,"median":24.702553,"eighty":30.374674,"marketCap":26014702030},{"date":"2022-04-29","current":41.717726,"twenty":12.617931,"median":24.768168,"eighty":30.481311,"marketCap":25853642688},{"date":"2022-05-06","current":40.037043,"twenty":12.672923,"median":24.835282,"eighty":30.64107,"marketCap":24117113377},{"date":"2022-05-13","current":40.258799,"twenty":12.697537,"median":24.934608,"eighty":30.867524,"marketCap":24250692555},{"date":"2022-05-20","current":39.835446,"twenty":12.713191,"median":25.066536,"eighty":30.997812,"marketCap":23995677761},{"date":"2022-05-27","current":41.599415,"twenty":12.727345,"median":25.116457,"eighty":31.059854,"marketCap":25058239402},{"date":"2022-06-03","current":40.843428,"twenty":12.733261,"median":25.194498,"eighty":31.165326,"marketCap":24602855842},{"date":"2022-06-10","current":40.803109,"twenty":12.735627,"median":25.334861,"eighty":31.219613,"marketCap":24578568718},{"date":"2022-06-17","current":39.664089,"twenty":12.739177,"median":25.403502,"eighty":31.585662,"marketCap":23892457487},{"date":"2022-06-24","current":43.54482,"twenty":12.746867,"median":25.497104,"eighty":32.196777,"marketCap":26230093099},{"date":"2022-07-01","current":43.081148,"twenty":12.778811,"median":25.671953,"eighty":32.432537,"marketCap":25950791181},{"date":"2022-07-08","current":43.302904,"twenty":12.783544,"median":25.758729,"eighty":32.51009,"marketCap":26084370359},{"date":"2022-07-15","current":44.280647,"twenty":12.872277,"median":25.81215,"eighty":32.913364,"marketCap":26673333098},{"date":"2022-07-22","current":43.575059,"twenty":12.909488,"median":25.883655,"eighty":37.112786,"marketCap":26248308441},{"date":"2022-07-29","current":43.837135,"twenty":12.927331,"median":25.924329,"eighty":37.494887,"marketCap":26406174742},{"date":"2022-08-05","current":55.302721,"twenty":12.943264,"median":26.008185,"eighty":37.641849,"marketCap":25776487684},{"date":"2022-08-12","current":57.582574,"twenty":12.984673,"median":26.031171,"eighty":37.739824,"marketCap":26839122629},{"date":"2022-08-19","current":57.452297,"twenty":13.031997,"median":26.064954,"eighty":37.955368,"marketCap":26778400632},{"date":"2022-08-26","current":56.084385,"twenty":13.049744,"median":26.130056,"eighty":38.170912,"marketCap":26140819665},{"date":"2022-09-02","current":54.807667,"twenty":13.070449,"median":26.166685,"eighty":38.396254,"marketCap":25545744095},{"date":"2022-09-09","current":56.839993,"twenty":13.104371,"median":26.235626,"eighty":38.531459,"marketCap":26493007247},{"date":"2022-09-16","current":54.651334,"twenty":13.130841,"median":26.335729,"eighty":38.654091,"marketCap":25472877699},{"date":"2022-09-23","current":52.540842,"twenty":13.157825,"median":26.35824,"eighty":38.942952,"marketCap":24489181349},{"date":"2022-09-30","current":52.345426,"twenty":13.203924,"median":26.443047,"eighty":39.5308,"marketCap":24398098354},{"date":"2022-10-07","current":53.231312,"twenty":13.220789,"median":26.570403,"eighty":39.868964,"marketCap":24811007933},{"date":"2022-10-14","current":53.947837,"twenty":13.238217,"median":26.594475,"eighty":40.109618,"marketCap":25144978916},{"date":"2022-10-21","current":53.439755,"twenty":13.287126,"median":26.637064,"eighty":40.381773,"marketCap":24908163128},{"date":"2022-10-28","current":55.706581,"twenty":13.343344,"median":26.697563,"eighty":40.596976,"marketCap":25964725874},{"date":"2022-11-04","current":54.638307,"twenty":13.42205,"median":26.813768,"eighty":40.835364,"marketCap":25466805499},{"date":"2022-11-11","current":52.620617,"twenty":13.438915,"median":26.87804,"eighty":41.030913,"marketCap":26669181236},{"date":"2022-11-18","current":51.362611,"twenty":13.477144,"median":26.991976,"eighty":41.419994,"marketCap":26031598351},{"date":"2022-11-25","current":51.494402,"twenty":13.508626,"median":27.128959,"eighty":41.588023,"marketCap":26098392749},{"date":"2022-12-02","current":52.53675,"twenty":13.524865,"median":27.163206,"eighty":41.70117,"marketCap":26626675710},{"date":"2022-12-09","current":50.020737,"twenty":13.531271,"median":27.175694,"eighty":42.099572,"marketCap":25351509941},{"date":"2022-12-16","current":48.175661,"twenty":13.536595,"median":27.242334,"eighty":42.522809,"marketCap":24416388376},{"date":"2022-12-23","current":47.253123,"twenty":13.555525,"median":27.46898,"eighty":42.883467,"marketCap":23948827594},{"date":"2022-12-30","current":47.348971,"twenty":13.573322,"median":27.509444,"eighty":43.081148,"marketCap":23997405338},{"date":"2023-01-06","current":45.635686,"twenty":13.58452,"median":27.609843,"eighty":43.15977,"marketCap":23129078171},{"date":"2023-01-13","current":47.169255,"twenty":13.602481,"median":27.828632,"eighty":43.302904,"marketCap":23906322069},{"date":"2023-01-20","current":45.92323,"twenty":13.638343,"median":27.953974,"eighty":43.369326,"marketCap":23274811402},{"date":"2023-01-27","current":46.606148,"twenty":13.663787,"median":28.075391,"eighty":43.492269,"marketCap":23620927825},{"date":"2023-02-03","current":46.678034,"twenty":13.677842,"median":28.635778,"eighty":43.575059,"marketCap":23657361133},{"date":"2023-02-10","current":45.647667,"twenty":13.700329,"median":28.791441,"eighty":44.018571,"marketCap":23135150389},{"date":"2023-02-17","current":536.452748,"twenty":13.744823,"median":28.985327,"eighty":45.527856,"marketCap":22977344089},{"date":"2023-02-24","current":515.754518,"twenty":13.745207,"median":29.047283,"eighty":45.638082,"marketCap":22090797514},{"date":"2023-03-03","current":505.263634,"twenty":13.756547,"median":29.121037,"eighty":45.865721,"marketCap":21641451990},{"date":"2023-03-10","current":469.254386,"twenty":13.824571,"median":29.181811,"eighty":46.294641,"marketCap":20099103841},{"date":"2023-03-17","current":491.086765,"twenty":13.863361,"median":29.214845,"eighty":46.433622,"marketCap":21034228309},{"date":"2023-03-24","current":502.286492,"twenty":13.889221,"median":29.284382,"eighty":46.639695,"marketCap":21513935017},{"date":"2023-03-31","current":510.792614,"twenty":13.89653,"median":29.384716,"eighty":46.953597,"marketCap":21878269226},{"date":"2023-04-06","current":514.195062,"twenty":13.908662,"median":29.389187,"eighty":46.991936,"marketCap":22024002909},{"date":"2023-04-14","current":517.881048,"twenty":13.930103,"median":29.629008,"eighty":47.183633,"marketCap":22181881066},{"date":"2023-04-21","current":511.926763,"twenty":14.003344,"median":29.811522,"eighty":47.38731,"marketCap":21926847120},{"date":"2023-04-28","current":501.012305,"twenty":14.059562,"median":29.901277,"eighty":48.453621,"marketCap":21459359029},{"date":"2023-05-05","current":494.632691,"twenty":14.081953,"median":30.06718,"eighty":50.15732,"marketCap":21186107429},{"date":"2023-05-12","current":63.132216,"twenty":14.097435,"median":30.121467,"eighty":50.607807,"marketCap":20949289375},{"date":"2023-05-19","current":61.532363,"twenty":14.125705,"median":30.273353,"eighty":51.046312,"marketCap":20418037790},{"date":"2023-05-26","current":58.989098,"twenty":14.148386,"median":30.350248,"eighty":51.427308,"marketCap":19574116514},{"date":"2023-06-02","current":60.690707,"twenty":14.160754,"median":30.36188,"eighty":51.544722,"marketCap":20138754490},{"date":"2023-06-09","current":63.179081,"twenty":14.184848,"median":30.416167,"eighty":52.19192,"marketCap":20964461638},{"date":"2023-06-16","current":58.915911,"twenty":14.243506,"median":30.482087,"eighty":52.539205,"marketCap":19549831009},{"date":"2023-06-23","current":56.738584,"twenty":14.315085,"median":30.602294,"eighty":52.629752,"marketCap":18827337255},{"date":"2023-06-29","current":54.158725,"twenty":14.348803,"median":30.610049,"eighty":52.716465,"marketCap":17971273226},{"date":"2023-07-07","current":55.787147,"twenty":14.368253,"median":30.7225,"eighty":53.147934,"marketCap":18511625698},{"date":"2023-07-14","current":56.189678,"twenty":14.385627,"median":30.817667,"eighty":53.439755,"marketCap":18645195972},{"date":"2023-07-21","current":57.031334,"twenty":14.406989,"median":30.912504,"eighty":53.523133,"marketCap":18924479272},{"date":"2023-07-28","current":56.720287,"twenty":14.411846,"median":30.997812,"eighty":53.911359,"marketCap":18821265879},{"date":"2023-08-04","current":55.970115,"twenty":14.415735,"median":31.028834,"eighty":54.260503,"marketCap":18572339459},{"date":"2023-08-11","current":72.162914,"twenty":14.43566,"median":31.102508,"eighty":54.461129,"marketCap":18397718410},{"date":"2023-08-18","current":69.094161,"twenty":14.479538,"median":31.168428,"eighty":54.648729,"marketCap":17615348965},{"date":"2023-08-25","current":69.778729,"twenty":14.509418,"median":31.203327,"eighty":54.763373,"marketCap":17789877534},{"date":"2023-09-01","current":70.392479,"twenty":14.580141,"median":31.269247,"eighty":54.978425,"marketCap":17946351423},{"date":"2023-09-08","current":68.126323,"twenty":14.602628,"median":31.455373,"eighty":55.107305,"marketCap":17368601679},{"date":"2023-09-15","current":67.890265,"twenty":14.667652,"median":31.928445,"eighty":55.289693,"marketCap":17308419414},{"date":"2023-09-22","current":61.988816,"twenty":14.847176,"median":32.246411,"eighty":55.641442,"marketCap":15803862789},{"date":"2023-09-29","current":63.216318,"twenty":14.859728,"median":32.339474,"eighty":55.973774,"marketCap":16116810567},{"date":"2023-10-06","current":62.767808,"twenty":15.016671,"median":32.482946,"eighty":56.080794,"marketCap":16002464263},{"date":"2023-10-13","current":63.971703,"twenty":15.066953,"median":32.556622,"eighty":56.189678,"marketCap":16309393815},{"date":"2023-10-20","current":66.355888,"twenty":15.150362,"median":32.773769,"eighty":56.544637,"marketCap":16917234691},{"date":"2023-10-27","current":64.32579,"twenty":15.218983,"median":32.928874,"eighty":56.599178,"marketCap":16399667212},{"date":"2023-11-03","current":64.868723,"twenty":16.726003,"median":36.907039,"eighty":56.712968,"marketCap":16538086422},{"date":"2023-11-10","current":88.80003,"twenty":21.996708,"median":37.21566,"eighty":56.826842,"marketCap":16375613449},{"date":"2023-11-17","current":85.949098,"twenty":22.092944,"median":37.494887,"eighty":56.889499,"marketCap":15849873215},{"date":"2023-11-24","current":87.765402,"twenty":22.177931,"median":37.592862,"eighty":57.067927,"marketCap":16184817745},{"date":"2023-12-01","current":65.305922,"twenty":22.190429,"median":37.666342,"eighty":57.217798,"marketCap":12043065075},{"date":"2023-12-08","current":69.407144,"twenty":22.271667,"median":37.730026,"eighty":57.452297,"marketCap":12799371342},{"date":"2023-12-15","current":69.069396,"twenty":22.390399,"median":37.75452,"eighty":57.77799,"marketCap":12737087296},{"date":"2023-12-22","current":66.053792,"twenty":22.540377,"median":37.955368,"eighty":58.915911,"marketCap":12180979747},{"date":"2023-12-29","current":67.453032,"twenty":22.562873,"median":37.997597,"eighty":59.09156,"marketCap":12439013650},{"date":"2024-01-05","current":67.067035,"twenty":22.579121,"median":38.02395,"eighty":59.439201,"marketCap":12367831884},{"date":"2024-01-12","current":69.021146,"twenty":22.595368,"median":38.190507,"eighty":60.273538,"marketCap":12728189575},{"date":"2024-01-19","current":67.646031,"twenty":22.640362,"median":38.303178,"eighty":60.799389,"marketCap":12474604533},{"date":"2024-01-26","current":70.227388,"twenty":22.677856,"median":38.50491,"eighty":61.532363,"marketCap":12950632595},{"date":"2024-02-02","current":69.19002,"twenty":22.884075,"median":38.587304,"eighty":61.916597,"marketCap":12759331598},{"date":"2024-02-09","current":69.23827,"twenty":22.890324,"median":38.625868,"eighty":62.198957,"marketCap":12768229319},{"date":"2024-02-16","current":11.82036,"twenty":22.884075,"median":38.696427,"eighty":62.821129,"marketCap":13414146195},{"date":"2024-02-23","current":12.210042,"twenty":22.58287,"median":38.613793,"eighty":62.778472,"marketCap":13856370795},{"date":"2024-03-01","current":11.942381,"twenty":22.255419,"median":38.523621,"eighty":62.312727,"marketCap":13552620565},{"date":"2024-03-08","current":11.824296,"twenty":20.664972,"median":38.430545,"eighty":62.163037,"marketCap":13418613110},{"date":"2024-03-15","current":11.749508,"twenty":15.016671,"median":38.210102,"eighty":62.021864,"marketCap":13333741722},{"date":"2024-03-22","current":11.977807,"twenty":14.597006,"median":38.097431,"eighty":61.966617,"marketCap":13592822801},{"date":"2024-03-28","current":11.98568,"twenty":14.455899,"median":37.997597,"eighty":61.934385,"marketCap":13601756631},{"date":"2024-04-05","current":11.30472,"twenty":14.395746,"median":37.829562,"eighty":61.889111,"marketCap":12828980310},{"date":"2024-04-12","current":11.434614,"twenty":14.190992,"median":37.744722,"eighty":61.843383,"marketCap":12976388510},{"date":"2024-04-19","current":10.978016,"twenty":14.097435,"median":37.720229,"eighty":61.737288,"marketCap":12458226353},{"date":"2024-04-26","current":11.170864,"twenty":13.930103,"median":37.622254,"eighty":61.590913,"marketCap":12677076753},{"date":"2024-05-03","current":11.429173,"twenty":13.857739,"median":37.494887,"eighty":61.301823,"marketCap":12970214422},{"date":"2024-05-10","current":15.790439,"twenty":13.745111,"median":37.220558,"eighty":61.104216,"marketCap":12613939409},{"date":"2024-05-17","current":15.739176,"twenty":13.753736,"median":37.112786,"eighty":60.998094,"marketCap":12573351116},{"date":"2024-05-24","current":15.157707,"twenty":13.808268,"median":34.822839,"eighty":60.858379,"marketCap":12108840655},{"date":"2024-05-31","current":14.898022,"twenty":13.852118,"median":32.773769,"eighty":60.755916,"marketCap":11901389381},{"date":"2024-06-07","current":15.331469,"twenty":13.879102,"median":32.556622,"eighty":60.617519,"marketCap":12247651204},{"date":"2024-06-14","current":15.393723,"twenty":13.894843,"median":32.486824,"eighty":60.463826,"marketCap":12297383268},{"date":"2024-06-21","current":15.071134,"twenty":13.897092,"median":32.455803,"eighty":60.288176,"marketCap":12039680751},{"date":"2024-06-28","current":15.093772,"twenty":13.904805,"median":32.339474,"eighty":60.258901,"marketCap":12057765138},{"date":"2024-07-05","current":14.669312,"twenty":13.920951,"median":32.246411,"eighty":60.178394,"marketCap":11718682879},{"date":"2024-07-12","current":15.127728,"twenty":13.960618,"median":31.928445,"eighty":60.006404,"marketCap":12084891719},{"date":"2024-07-15","current":15.150366,"twenty":13.981981,"median":31.796605,"eighty":59.980789,"marketCap":12102976106},{"date":"2024-08-02","current":16.123793,"twenty":14.003344,"median":31.734563,"eighty":59.955173,"marketCap":12880604754},{"date":"2024-08-09","current":17.406437,"twenty":14.059562,"median":31.277002,"eighty":59.651445,"marketCap":11718640189},{"date":"2024-08-16","current":18.245141,"twenty":14.081953,"median":31.218837,"eighty":59.351376,"marketCap":12283285949},{"date":"2024-08-23","current":18.458146,"twenty":14.097435,"median":31.168428,"eighty":59.252573,"marketCap":12426688047},{"date":"2024-08-30","current":19.390039,"twenty":14.125705,"median":31.141285,"eighty":59.09156,"marketCap":13054072226},{"date":"2024-09-06","current":19.350101,"twenty":14.146138,"median":31.063732,"eighty":58.974461,"marketCap":13027184332},{"date":"2024-09-13","current":18.338331,"twenty":14.160754,"median":31.005568,"eighty":58.937867,"marketCap":12346024367},{"date":"2024-09-20","current":18.631211,"twenty":14.184848,"median":30.990057,"eighty":58.879317,"marketCap":12543202252},{"date":"2024-09-27","current":18.764339,"twenty":14.243506,"median":30.904749,"eighty":58.641458,"marketCap":12632828563},{"date":"2024-10-04","current":18.471458,"twenty":14.326324,"median":30.775014,"eighty":58.287732,"marketCap":12435650679},{"date":"2024-10-11","current":18.298392,"twenty":14.368253,"median":30.610049,"eighty":58.012489,"marketCap":12319136474},{"date":"2024-10-18","current":18.67115,"twenty":14.390686,"median":30.54413,"eighty":57.699824,"marketCap":12570090145},{"date":"2024-10-25","current":18.158608,"twenty":14.408114,"median":30.465593,"eighty":57.566941,"marketCap":12225028847},{"date":"2024-10-31","current":18.098701,"twenty":14.411846,"median":30.382231,"eighty":57.528884,"marketCap":12184697007},{"date":"2024-11-08","current":10.289745,"twenty":14.406989,"median":30.354125,"eighty":57.466826,"marketCap":11782880049},{"date":"2024-11-15","current":9.925026,"twenty":14.223393,"median":30.330859,"eighty":57.444951,"marketCap":11365236488},{"date":"2024-11-22","current":10.243185,"twenty":14.10977,"median":30.171876,"eighty":57.378974,"marketCap":11729563850},{"date":"2024-11-29","current":10.344065,"twenty":14.04607,"median":30.088852,"eighty":57.232599,"marketCap":11845082282},{"date":"2024-12-06","current":10.239305,"twenty":13.894281,"median":29.997383,"eighty":57.230825,"marketCap":11725120833},{"date":"2024-12-13","current":9.781466,"twenty":13.745303,"median":29.892686,"eighty":57.217798,"marketCap":11200844873},{"date":"2024-12-20","current":9.420627,"twenty":13.663787,"median":29.795746,"eighty":57.141115,"marketCap":10787644329},{"date":"2024-12-27","current":9.855186,"twenty":13.579288,"median":29.601864,"eighty":57.126477,"marketCap":11285262189},{"date":"2025-01-03","current":10.006506,"twenty":13.531271,"median":29.389187,"eighty":57.100862,"marketCap":11458539837},{"date":"2025-01-10","current":10.165586,"twenty":13.458029,"median":29.384716,"eighty":57.078905,"marketCap":11640703518},{"date":"2025-01-17","current":12.008583,"twenty":13.264639,"median":29.284382,"eighty":57.05329,"marketCap":13751136407},{"date":"2025-01-24","current":11.880543,"twenty":13.173566,"median":29.224184,"eighty":57.011305,"marketCap":13604516859},{"date":"2025-01-31","current":12.256903,"twenty":13.053885,"median":29.19859,"eighty":56.923371,"marketCap":14035489470},{"date":"2025-02-07","current":12.183183,"twenty":12.930518,"median":29.127468,"eighty":56.889499,"marketCap":13951072155},{"date":"2025-02-14","current":16.37486,"twenty":12.913057,"median":29.097649,"eighty":56.873866,"marketCap":14065726416},{"date":"2025-02-21","current":16.813743,"twenty":12.927331,"median":28.991567,"eighty":56.853021,"marketCap":14442719083},{"date":"2025-02-28","current":16.833921,"twenty":12.943264,"median":28.872386,"eighty":56.839993,"marketCap":14460052079},{"date":"2025-03-07","current":16.788519,"twenty":12.984673,"median":28.666911,"eighty":56.830068,"marketCap":14421052838},{"date":"2025-03-14","current":16.485842,"twenty":13.031997,"median":28.143472,"eighty":56.813938,"marketCap":14161057895},{"date":"2025-03-21","current":16.899501,"twenty":13.049744,"median":27.981993,"eighty":56.738584,"marketCap":14516384317},{"date":"2025-03-28","current":15.966245,"twenty":13.070449,"median":27.828632,"eighty":56.720287,"marketCap":13714733243},{"date":"2025-04-04","current":16.03687,"twenty":13.112851,"median":27.609843,"eighty":56.720287,"marketCap":13775398729},{"date":"2025-04-11","current":15.744282,"twenty":13.135338,"median":27.489212,"eighty":56.683693,"marketCap":13524070285},{"date":"2025-04-17","current":16.238655,"twenty":13.157825,"median":27.373688,"eighty":56.63978,"marketCap":13948728691},{"date":"2025-04-25","current":16.157941,"twenty":13.203924,"median":27.227853,"eighty":56.610156,"marketCap":13879396707},{"date":"2025-05-02","current":16.384949,"twenty":13.220789,"median":27.175409,"eighty":56.605494,"marketCap":14074392914},{"date":"2025-05-09","current":13.13487,"twenty":13.220789,"median":27.160092,"eighty":56.580228,"marketCap":14343054355},{"date":"2025-05-16","current":12.773553,"twenty":13.130466,"median":27.076244,"eighty":56.544637,"marketCap":13955796159},{"date":"2025-05-23","current":12.461156,"twenty":13.066308,"median":26.904805,"eighty":56.28848,"marketCap":13614485927},{"date":"2025-05-30","current":12.588429,"twenty":12.968109,"median":26.873672,"eighty":56.212937,"marketCap":13753538244},{"date":"2025-06-06","current":13.016528,"twenty":12.90448,"median":26.797021,"eighty":56.195426,"marketCap":14221259673},{"date":"2025-06-13","current":13.602754,"twenty":12.90448,"median":26.668197,"eighty":56.189678,"marketCap":14861743072},{"date":"2025-06-20","current":13.463911,"twenty":12.933704,"median":26.697563,"eighty":56.189678,"marketCap":14710049635},{"date":"2025-06-27","current":13.602754,"twenty":12.933704,"median":26.697563,"eighty":56.189678,"marketCap":14861743072},{"date":"2025-07-03","current":14.026996,"twenty":12.933704,"median":26.697563,"eighty":56.189678,"marketCap":15325250795},{"date":"2025-07-11","current":13.930577,"twenty":12.933704,"median":26.697563,"eighty":56.189678,"marketCap":15219908130},{"date":"2025-07-18","current":13.679889,"twenty":12.997415,"median":26.697563,"eighty":56.189678,"marketCap":14946017203},{"date":"2025-07-25","current":14.111845,"twenty":13.115975,"median":26.697563,"eighty":56.189678,"marketCap":15417952339},{"date":"2025-08-01","current":14.192836,"twenty":13.181814,"median":26.697563,"eighty":56.189678,"marketCap":15506440177},{"date":"2025-08-08","current":15.6743,"twenty":13.310592,"median":26.697563,"eighty":56.189678,"marketCap":15999165780},{"date":"2025-08-15","current":15.458307,"twenty":13.437714,"median":26.697563,"eighty":56.189678,"marketCap":15778696325},{"date":"2025-08-22","current":15.37784,"twenty":13.501317,"median":26.697563,"eighty":56.189678,"marketCap":15696560645},{"date":"2025-08-29","current":15.085614,"twenty":13.602754,"median":26.697563,"eighty":56.189678,"marketCap":15398278441},{"date":"2025-09-05","current":15.627714,"twenty":13.682974,"median":26.726929,"eighty":56.189678,"marketCap":15951613545},{"date":"2025-09-12","current":15.54301,"twenty":13.727713,"median":26.697563,"eighty":56.189678,"marketCap":15865154935},{"date":"2025-09-19","current":15.132201,"twenty":13.827216,"median":26.697563,"eighty":56.189678,"marketCap":15445830676},{"date":"2025-09-26","current":14.780683,"twenty":13.857345,"median":26.697563,"eighty":56.189678,"marketCap":15087027445},{"date":"2025-10-03","current":15.454072,"twenty":13.907401,"median":26.697563,"eighty":56.189678,"marketCap":15774373394},{"date":"2025-10-10","current":15.305842,"twenty":13.996913,"median":26.697563,"eighty":56.189678,"marketCap":15623070827},{"date":"2025-10-17","current":15.390545,"twenty":14.093333,"median":26.697563,"eighty":56.189678,"marketCap":15709529437},{"date":"2025-10-24","current":15.606538,"twenty":14.18067,"median":26.697563,"eighty":56.189678,"marketCap":15929998892},{"date":"2025-10-31","current":15.644654,"twenty":14.376689,"median":26.697563,"eighty":56.189678,"marketCap":15968905267},{"date":"2025-11-07","current":22.776673,"twenty":14.487757,"median":26.697563,"eighty":56.189678,"marketCap":17423152601},{"date":"2025-11-14","current":22.190221,"twenty":14.585763,"median":26.697563,"eighty":56.189678,"marketCap":16974542737},{"date":"2025-11-21","current":21.441797,"twenty":14.71386,"median":26.697563,"eighty":56.189678,"marketCap":16402031102},{"date":"2025-11-28","current":22.352193,"twenty":14.852999,"median":26.697563,"eighty":56.189678,"marketCap":17098444509},{"date":"2025-12-05","current":21.866276,"twenty":14.925958,"median":26.697563,"eighty":56.189678,"marketCap":16726739194},{"date":"2025-12-12","current":21.676378,"twenty":15.032381,"median":26.697563,"eighty":56.189678,"marketCap":16581475048},{"date":"2025-12-19","current":21.464138,"twenty":15.093897,"median":26.697563,"eighty":56.189678,"marketCap":16419121002},{"date":"2025-12-26","current":21.922129,"twenty":15.149631,"median":26.697563,"eighty":56.189678,"marketCap":16769463943},{"date":"2026-01-02","current":21.581428,"twenty":15.187258,"median":26.697563,"eighty":56.189678,"marketCap":16508842974},{"date":"2026-01-09","current":22.48624,"twenty":15.23808,"median":26.697563,"eighty":56.189678,"marketCap":17200983907},{"date":"2026-01-16","current":22.184636,"twenty":15.252479,"median":26.697563,"eighty":56.189678,"marketCap":16970270263},{"date":"2026-01-23","current":22.402461,"twenty":15.277931,"median":26.697563,"eighty":56.189678,"marketCap":17136896783},{"date":"2026-01-30","current":22.821355,"twenty":15.310924,"median":26.697563,"eighty":56.189678,"marketCap":17457332400},{"date":"2026-02-06","current":24.630978,"twenty":15.328798,"median":26.697563,"eighty":56.189678,"marketCap":18841614264},{"date":"2026-02-13","current":24.895555,"twenty":15.360052,"median":26.697563,"eighty":56.189678,"marketCap":19193153817},{"date":"2026-02-20","current":25.067824,"twenty":15.379534,"median":26.630837,"eighty":56.189678,"marketCap":19325963587},{"date":"2026-02-26","current":25.090052,"twenty":15.379534,"median":26.576164,"eighty":56.189678,"marketCap":19343100331}],"updateTime":1772268752097},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RPRX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2607407520","title":"UBS Upgrades Royalty Pharma to Buy From Neutral, Adjusts Price Target to $49 From $38","url":"https://stock-news.laohu8.com/highlight/detail?id=2607407520","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607407520?lang=en_us&edition=fundamental","pubTime":"2026-01-31 00:30","pubTimestamp":1769790648,"startTime":"0","endTime":"0","summary":"Royalty Pharma (RPRX) has an average rating of buy and mean price target of $48.71, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major bank","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","RPRX"],"gpt_icon":0},{"id":"2607706409","title":"Assessing Royalty Pharma (RPRX) Valuation After Teva Autoimmune Funding Partnership Attracts Fresh Attention","url":"https://stock-news.laohu8.com/highlight/detail?id=2607706409","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607706409?lang=en_us&edition=fundamental","pubTime":"2026-01-29 11:45","pubTimestamp":1769658307,"startTime":"0","endTime":"0","summary":"Why Royalty Pharma’s latest funding deal matters\nRoyalty Pharma (RPRX) has moved into focus after announcing a funding partnership with Teva Pharmaceuticals to speed up clinical development of an anti IL 15 antibody for autoimmune diseases.\nThis agreement highlights how Royalty Pharma deploys capital into biopharma projects, with investors watching how the Teva collaboration fits into its existing portfolio of marketed therapies and development stage candidates.\nSee our latest analysis for...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rprx/royalty-pharma/news/assessing-royalty-pharma-rprx-valuation-after-teva-autoimmun","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rprx/royalty-pharma/news/assessing-royalty-pharma-rprx-valuation-after-teva-autoimmun","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["RPRX","BK4007"],"gpt_icon":0},{"id":"2606738080","title":"Royalty Pharma Is Maintained at Buy by Citigroup","url":"https://stock-news.laohu8.com/highlight/detail?id=2606738080","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606738080?lang=en_us&edition=fundamental","pubTime":"2026-01-27 22:50","pubTimestamp":1769525400,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/RPRX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 27, 2026 09:50 ET (14:50 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RPRX","BK4007"],"gpt_icon":0},{"id":"2606226643","title":"Royalty Pharma EVP Marshall Urist Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2606226643","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606226643?lang=en_us&edition=fundamental","pubTime":"2026-01-27 05:11","pubTimestamp":1769461899,"startTime":"0","endTime":"0","summary":"Marshall Urist, Executive Vice President of Research & Investments at Royalty Pharma plc, reported a disposal of common shares of Royalty Pharma plc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Royalty Pharma plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 26, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260126:nNDL3RSnQm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Royalty Pharma EVP Marshall Urist Reports Disposal of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RPRX","BK4007"],"gpt_icon":0},{"id":"2605186144","title":"EVP Marshall Urist Reports Disposal of Royalty Pharma plc Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2605186144","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605186144?lang=en_us&edition=fundamental","pubTime":"2026-01-21 06:01","pubTimestamp":1768946464,"startTime":"0","endTime":"0","summary":"Marshall Urist, EVP, Research & Investments of Royalty Pharma plc, reported a disposal of common shares of Royalty Pharma plc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Royalty Pharma plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 20, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nNDL9YFfhv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"EVP Marshall Urist Reports Disposal of Royalty Pharma plc Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RPRX","BK4007"],"gpt_icon":0},{"id":"2605149743","title":"Royalty Pharma plc to Announce Fourth Quarter and Full Year 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2605149743","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605149743?lang=en_us&edition=fundamental","pubTime":"2026-01-21 05:15","pubTimestamp":1768943740,"startTime":"0","endTime":"0","summary":"Royalty Pharma plc will announce its fourth quarter and full year 2025 financial results on Wednesday, February 11, 2026, before the U.S. financial markets open. The results will be released on the \"Investors\" page of the company's website. A conference call and simultaneous webcast will be held at 8:00 a.m. Eastern Time on the same day. For more details and to access the live webcast, visit the Investors page on the Royalty Pharma website.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Royalty Pharma plc published the original content used to generate this news brief via GlobeNewswire  on January 20, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nNDL1l4zhY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","BK4007","LU0314104364.USD","LU2095319765.USD","LU2210150020.SGD","IE00BKPKM429.USD","SG9999014039.USD","BK4588","SG9999014013.SGD","RPRX","SG9999014005.SGD","IE00B3QW5Z07.USD","BK4112","LU2210149790.SGD","IE00BGHQF748.EUR","NDAQ","BK4585","SG9999014021.USD"],"gpt_icon":0},{"id":"2603655981","title":"Royalty Pharma EVP Marshall Urist Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2603655981","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603655981?lang=en_us&edition=fundamental","pubTime":"2026-01-14 06:38","pubTimestamp":1768343903,"startTime":"0","endTime":"0","summary":"Marshall Urist, EVP, Research & Investments at Royalty Pharma plc, reported a disposal of common shares of Royalty Pharma plc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Royalty Pharma plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 13, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nNDL4MDx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Royalty Pharma EVP Marshall Urist Reports Sale of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RPRX"],"gpt_icon":0},{"id":"2602517360","title":"Royalty Pharma provides update on business performance","url":"https://stock-news.laohu8.com/highlight/detail?id=2602517360","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602517360?lang=en_us&edition=fundamental","pubTime":"2026-01-12 20:36","pubTimestamp":1768221382,"startTime":"0","endTime":"0","summary":"Royalty Pharma (RPRX) provided an update on its business performance, including recent key accomplishments. Key highlights include: Royalty funding...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/royalty-pharma-provides-update-on-business-performance-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/royalty-pharma-provides-update-on-business-performance-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RPRX","BK4007"],"gpt_icon":0},{"id":"2602355512","title":"Royalty Pharma Targets 14%-16% Top-Line Growth for 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2602355512","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602355512?lang=en_us&edition=fundamental","pubTime":"2026-01-12 20:15","pubTimestamp":1768220113,"startTime":"0","endTime":"0","summary":"Royalty Pharma plc announced that it is on track to deliver its full-year guidance for 14%-16% top-line growth, as discussed during its third quarter 2025 earnings call. The company highlighted a landmark year in 2025, with $4.7 billion in royalty transactions and the royalty market reaching $10 billion for the first time. Royalty Pharma also noted that it has maintained its track record of double-digit growth during this period.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Royalty Pharma plc published the original content used to generate this news brief via GlobeNewswire  on January 12, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nNDLb3httq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","LU2210150020.SGD","SG9999014021.USD","BK4007","IE00BGHQF748.EUR","RPRX","NDAQ","SG9999014039.USD","BK4585","IE00B64PRP62.GBP","LU2095319765.USD","SG9999014005.SGD","IE00B3QW5Z07.USD","IE00BKPKM429.USD","LU0314104364.USD","SG9999014013.SGD","BK4588","LU2210149790.SGD"],"gpt_icon":0},{"id":"2602123615","title":"Royalty Pharma to Highlight Accomplishments and Provide Business Update at 44TH Annual J.p. Morgan Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2602123615","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602123615?lang=en_us&edition=fundamental","pubTime":"2026-01-12 20:15","pubTimestamp":1768220100,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nTUA7CJHTP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","RPRX"],"gpt_icon":0},{"id":"2602635685","title":"Royalty Pharma, Teva enter agreement to accelerate development of TEV-‘408","url":"https://stock-news.laohu8.com/highlight/detail?id=2602635685","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602635685?lang=en_us&edition=fundamental","pubTime":"2026-01-12 06:20","pubTimestamp":1768170007,"startTime":"0","endTime":"0","summary":"Royalty Pharma (RPRX) and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries (TEVA), announced a funding agreement of up to $...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/royalty-pharma-teva-enter-agreement-to-accelerate-development-of-tev-408-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/royalty-pharma-teva-enter-agreement-to-accelerate-development-of-tev-408-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4566","LU1983299246.USD","BK4585","RPRX","BK4584","TEVA","BK4559","BK4596","BK4557","BK4007"],"gpt_icon":0},{"id":"2602568024","title":"BRIEF-Teva And Royalty Pharma Enter Agreement To Accelerate Development Of Potential Treatment For Vitiligo","url":"https://stock-news.laohu8.com/highlight/detail?id=2602568024","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602568024?lang=en_us&edition=fundamental","pubTime":"2026-01-12 06:16","pubTimestamp":1768169770,"startTime":"0","endTime":"0","summary":"BRIEF-Teva And Royalty Pharma Enter Agreement To Accelerate Development Of Potential Treatment For VitiligoJan 11 (Reuters) - Royalty Pharma PLC RPRX.O:TEVA AND ROYALTY PHARMA ENTER AGREEMENT TO ACCEL","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260111:nFWN3YA0ZI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RPRX"],"gpt_icon":0},{"id":"2602856872","title":"Teva and Royalty Pharma Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo","url":"https://stock-news.laohu8.com/highlight/detail?id=2602856872","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602856872?lang=en_us&edition=fundamental","pubTime":"2026-01-12 06:07","pubTimestamp":1768169235,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260111:nFWN3YA0ZI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RPRX","BK4007"],"gpt_icon":0},{"id":"2602568723","title":"Teva - Teva to Share Tev-'408 Trial Results in 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2602568723","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602568723?lang=en_us&edition=fundamental","pubTime":"2026-01-12 06:07","pubTimestamp":1768169235,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260111:nFWN3YA0ZI:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","RPRX"],"gpt_icon":0},{"id":"2602568722","title":"Royalty Pharma  - to Provide up to $500 Mln for Teva's Tev-'408","url":"https://stock-news.laohu8.com/highlight/detail?id=2602568722","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602568722?lang=en_us&edition=fundamental","pubTime":"2026-01-12 06:07","pubTimestamp":1768169235,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260111:nFWN3YA0ZI:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","RPRX"],"gpt_icon":0},{"id":"2602456872","title":"Royalty Pharma : Tev-'408 Is Currently in Phase 1B for Treatment of Vitiligo and in Phase 2a for Celiac Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2602456872","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602456872?lang=en_us&edition=fundamental","pubTime":"2026-01-12 06:07","pubTimestamp":1768169235,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260111:nFWN3YA0ZI:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","RPRX"],"gpt_icon":0},{"id":"2602568227","title":"Teva and Royalty Pharma Partner in $500 Million Deal to Advance TEV-'408 for Vitiligo","url":"https://stock-news.laohu8.com/highlight/detail?id=2602568227","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602568227?lang=en_us&edition=fundamental","pubTime":"2026-01-12 06:00","pubTimestamp":1768168824,"startTime":"0","endTime":"0","summary":"Teva Pharmaceutical Industries Ltd. has entered into a funding agreement with Royalty Pharma plc to accelerate the clinical development of Teva's anti-IL-15 antibody, TEV-'408, for the treatment of vitiligo and other autoimmune diseases. Under the terms of the agreement, Royalty Pharma will provide up to $500 million to support ongoing research and development, including $75 million to fund a Phase 2b study starting in 2026. Pending positive results from this study, Royalty Pharma has the option to invest an additional $425 million to support Phase 3 development. If TEV-'408 is approved and launched, Teva will pay Royalty Pharma a milestone payment and royalties on global net sales.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Teva P","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260111:nNDL4rM5QB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","SG9999014013.SGD","LU2210149790.SGD","RPRX","BK4585","SG9999014021.USD","LU2210150020.SGD","IE00BKPKM429.USD","SG9999014039.USD","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","LU0314104364.USD","NDAQ","BK4112","SG9999014005.SGD","LU2095319765.USD","IE00BGHQF748.EUR","BK4007"],"gpt_icon":0},{"id":"2602587557","title":"Assessing Royalty Pharma (RPRX) Valuation After Dividend Increase And Raised Full Year Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2602587557","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602587557?lang=en_us&edition=fundamental","pubTime":"2026-01-10 18:23","pubTimestamp":1768040608,"startTime":"0","endTime":"0","summary":"Royalty Pharma (RPRX) has drawn fresh attention after its board approved a 6.8% increase in the quarterly dividend to US$0.235 per Class A share, along with raised full year guidance following recent results.\nSee our latest analysis for Royalty Pharma.\nThe dividend increase and higher full year guidance come after a period of improving momentum, with the share price at US$40.17, a 90 day share price return of 11.55% and a 1 year total shareholder return of 39.65%, suggesting sentiment has...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rprx/royalty-pharma/news/assessing-royalty-pharma-rprx-valuation-after-dividend-incre","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rprx/royalty-pharma/news/assessing-royalty-pharma-rprx-valuation-after-dividend-incre","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","RPRX"],"gpt_icon":0},{"id":"2602137916","title":"Royalty Pharma Increases Quarterly Dividend to $0.235 a Share From $0.22, Payable March 10 to Holders of Record on Feb. 20.","url":"https://stock-news.laohu8.com/highlight/detail?id=2602137916","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602137916?lang=en_us&edition=fundamental","pubTime":"2026-01-09 21:45","pubTimestamp":1767966303,"startTime":"0","endTime":"0","summary":"Royalty Pharma Increases Quarterly Dividend to $0.235 a Share From $0.22, Payable March 10 to Holders of Record on Feb. 20.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RPRX","BK4007"],"gpt_icon":0},{"id":"2602376021","title":"Royalty Pharma announces $0.235 quarterly dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2602376021","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602376021?lang=en_us&edition=fundamental","pubTime":"2026-01-09 21:30","pubTimestamp":1767965423,"startTime":"0","endTime":"0","summary":"Royalty Pharma plc has announced a first quarter 2026 dividend of $0.235 per Class A ordinary share, representing a 6.8% increase over the previous quarter's dividend.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Royalty Pharma plc published the original content used to generate this news brief via GlobeNewswire  on January 09, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260109:nNDL1w0H5D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","LU2210150020.SGD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","SG9999014039.USD","NDAQ","LU2095319765.USD","BK4585","RPRX","BK4588","LU2210149790.SGD","BK4112","SG9999014013.SGD","SG9999014005.SGD","SG9999014021.USD","IE00BKPKM429.USD","BK4007","IE00B3QW5Z07.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":2,"totalSize":96,"code":"91000000","status":"200"}]}}